Hyperprolactinemia and Adrenal Steroidogenesis

NCT04146389 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2023-12-06

No results posted yet for this study

Summary

The purpose of this study is to explore the effects of prolactin on adrenal steroid profiles in patients with hyperprolactinemia due to prolactinomas before and after initialisation of treatment.

Conditions

  • Hyperprolactinemia

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Lia Bally, MD PhD · Inselspital, Bern University Hospital, University of Bern

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-24
Primary Completion
2023-11-06
Completion
2023-11-06

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146389 on ClinicalTrials.gov